PEPTOMYC

Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years. Currently, cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by... 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance. Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.

#SimilarOrganizations #People #Financial #Website #More

PEPTOMYC

Social Links:

Youtube

Industry:

Biotechnology Health Care Wellness

Founded:

2014-12-01

Address:

Barcelona, Catalonia, Spain

Country:

Spain

Website Url:

http://www.peptomyc.com

Total Employee:

11+

Status:

Active

Total Funding:

22.79 M EUR

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Cloudflare JS CDN JS WordPress 6.0

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

Current Employees Featured

laura-soucek_image

Laura Soucek
Laura Soucek Founder and Chief Executive Officer @ Peptomyc
Founder and Chief Executive Officer
2014-12-01

marie-eve-beaulieu_image

Marie-Eve Beaulieu
Marie-Eve Beaulieu Co-Founder & Chief Scientific Officer @ Peptomyc
Co-Founder & Chief Scientific Officer
2016-07-01

Founder

laura-soucek_image

Laura Soucek

marie-eve-beaulieu_image

Marie-Eve Beaulieu

Investors List

healthequity-2_image

Official Site Inspections

http://www.peptomyc.com Semrush global rank: 8.54 M Semrush visits lastest month: 295

Host Informations
Whois Informations

Loading ...